Pixelgen Technologies
Pixelgen Technologies Raises $15.5M Series B for Cell Mapping Platform
Pixelgen Technologies announced $15.5M in Series B financing on August 20, 2026. Pixelgen Technologies raised a $15.5 million Series B led by new investor Flat Capital to accelerate global commercialization of its Proxiome Kit.
Round details
The financing includes backing from Flat Capital, Industrifonden, Navigare Ventures. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $15.5M
- Headquarters: Stockholm, Sweden
How the company plans to use the capital
Pixelgen said the funds will accelerate global commercialization of its Proxiome Kit and expand the company’s presence in key markets. The company also said the financing will help it grow its team and product portfolio.
Why this matters for GTM teams
The round was described as oversubscribed, with continued participation from existing investors Industrifonden and Navigare Ventures alongside new lead investor Flat Capital.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Pixelgen Technologies Series B announcement.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started